Skip to search formSkip to main contentSkip to account menu
Cannabis induces a clinical response in patients with Crohn's disease: a prospective placebo-controlled study.
View on PubMed
Prospective analysis of safety and efficacy of medical cannabis in large unselected population of patients with cancer.
View on PubMed
Safety and Efficacy of Medical Cannabis in Fibromyalgia
TLDR
Medical cannabis appears to be a safe and effective alternative for the treatment of fibromyalgia symptoms and standardization of treatment compounds and regimens are required.
View PDF
Medical Cannabis in Parkinson Disease: Real-Life Patients' Experience
TLDR
Medical cannabis was found to improve symptoms of PD in the initial stages of treatment and did not cause major adverse effects in this pilot, 2-center, retrospective survey.
View on Wolters Kluwer
Real life Experience of Medical Cannabis Treatment in Autism: Analysis of Safety and Efficacy
TLDR
Cannabis in ASD patients appears to be well tolerated, safe and effective option to relieve symptoms associated with ASD and its safety and efficacy is described.
View on Springer
Medical cannabis for inflammatory bowel disease: real-life experience of mode of consumption and assessment of side-effects.
TLDR
Cannabis use by inflammatory bowel disease patients can induce clinical improvement and is associated with reduced use of medication and slight weight gain, and most patients respond well to a dose of 30 g/month, or 21 mg Ī”9-tetra- hydrocannabinol and 170 mg Cannabidiol (CBD) per day.
View on PubMed
Medical cannabis: aligning use to evidenceā€based medicine approach
TLDR
Israel has created a medical and regulatory environment that enables clinical studies with cannabis which may lead to improved Evidence Based use of these compounds.
View on Wolters Kluwer
Oral CBD-rich cannabis induces clinical but not endoscopic response in patients with Crohn's disease, a randomized controlled trial.
TLDR
Until further studies are available, cannabis treatment in Crohn's disease should be used only in the context of clinical trials.
View on PubMed
Cannabis is associated with clinical but not endoscopic remission in ulcerative colitis: A randomized controlled trial.
TLDR
Short term treatment with THC rich cannabis induced clinical remission and improved quality of life in patients with mild to moderately active ulcerative colitis, however, these beneficial clinical effects were not associated with significant anti-inflammatory improvement in the Mayo endoscopic score or laboratory markers for inflammation.
View PDF
Adherence, Safety, and Effectiveness of Medical Cannabis and Epidemiological Characteristics of the Patient Population: A Prospective Study
TLDR
It is observed that supervised medical-cannabis treatment is associated with high adherence, improvement in quality of life, and a decrease in pain level with a low incidence of serious adverse events.
View on PubMed
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License